ClinicalTrials.gg

Program

R-3750

A development code.

Its studies are mostly in Crohn Disease · Colitis, Ulcerative · Respiratory Distress Syndrome · Pulmonary Disease, Chronic Obstructive, led by Rise Therapeutics.

Furthest: phase 1, since Dec 1, 20224 company-led studies, 4 open or runningNext primary completion: Apr 30, 2028 (phase 1)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Rise Therapeutics44 open or runningphase 1since Dec 1, 2022Dec 1, 2022Apr 30, 2028phase 1 · NCT07076290

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Dec 1, 2022First study: phase 1 study in Colitis, UlcerativeFirst studyNCT05666960 · 36 planned · United States
  2. Jul 14, 2025Phase 1 study in Pulmonary Disease, Chronic ObstructiveNCT07076290 · 27 planned
  3. Jun 5, 2026Phase 1 study in Respiratory Distress SyndromeNCT07646028 · 20 planned
  4. Aug 18, 2026Phase 1 study in Crohn DiseaseNCT07791888 · 40 planned

Ahead

  1. Apr 30, 2028Primary completion: phase 1 study in Pulmonary Disease, Chronic ObstructiveNCT07076290
  2. Oct 31, 2028Primary completion: phase 1 study in Respiratory Distress SyndromeNCT07646028
  3. Dec 31, 2028Primary completion: phase 1 study in Crohn DiseaseNCT07791888

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 4 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07791888Crohn Disease1Not yet recruitingDec 31, 202840
NCT07646028Respiratory Distress Syndrome1Not yet recruitingOct 31, 202820
NCT07076290Pulmonary Disease, Chronic Obstructive1Not yet recruitingApr 30, 202827
NCT05666960Colitis, Ulcerative · United States1RecruitingJul 202636

How it is read

Names in the registry

  • “R-3750”, 4 entries

Codes read as this program: R3750.

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.